It is also worth mentioning that the inactivation of 53BP1 was shown to potentiate homologous recombination and increase DNA damage tolerance of cancer-prone BRCA1 -/- cells [32], [76], [77], [78], with severe implications for therapeutic treatments. Here, BRCA1 is linked to cancer.